BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35519053)

  • 1. Quinazoline-Schiff base conjugates:
    Mansour MA; AboulMagd AM; Abdel-Rahman HM
    RSC Adv; 2020 Sep; 10(56):34033-34045. PubMed ID: 35519053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
    Vijayakumar BG; Ramesh D; Joji A; Jayachandra Prakasan J; Kannan T
    Eur J Pharmacol; 2020 Nov; 886():173448. PubMed ID: 32768503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
    Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
    J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase
    Elkaeed EB; Alsfouk BA; Ibrahim TH; Arafa RK; Elkady H; Ibrahim IM; Eissa IH; Metwaly AM
    Antivir Ther; 2023 Oct; 28(5):13596535231199838. PubMed ID: 37669909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
    Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and In Silico Investigation of Isatin-Based Schiff Bases as Potential Inhibitors for Promising Targets against SARS-CoV-2.
    Esam Z; Akhavan M; Lotfi M; Bekhradnia A
    ChemistrySelect; 2022 Dec; 7(46):e202201983. PubMed ID: 36718466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.
    Alagarsamy V; Solomon VR; Sundar PS; Kulkarni VS; Sulthana MT; Aishwarya AD; Narendhar B; Murugesan S
    Curr Comput Aided Drug Des; 2023; 19(1):51-67. PubMed ID: 36424783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp.
    Zhao J; Zhang Y; Wang M; Liu Q; Lei X; Wu M; Guo S; Yi D; Li Q; Ma L; Liu Z; Guo F; Wang J; Li X; Wang Y; Cen S
    ACS Infect Dis; 2021 Jun; 7(6):1535-1544. PubMed ID: 34038639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study.
    Rameshkumar MR; Indu P; Arunagirinathan N; Venkatadri B; El-Serehy HA; Ahmad A
    Saudi J Biol Sci; 2021 Jan; 28(1):448-458. PubMed ID: 33110386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 M
    Mohamed NM; Ali EMH; AboulMagd AM
    RSC Adv; 2021 Jan; 11(8):4523-4538. PubMed ID: 35747608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of phytoconstituents of
    Choudhary P; Singh T; Amod A; Singh S
    J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis.
    Liu J; Zhang L; Gao J; Zhang B; Liu X; Yang N; Liu X; Liu X; Cheng Y
    Front Pharmacol; 2022; 13():961154. PubMed ID: 36091808
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19.
    Esam Z; Akhavan M; Lotfi M; Pourmand S; Bekhradnia A
    Chem Zvesti; 2023; 77(2):1129-1148. PubMed ID: 36312321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, computational analyses, in silico ADMET studies, and inhibitory action against SARS-CoV-2 main protease (Mpro) of a Schiff base.
    Şahin S; Dege N
    Turk J Chem; 2022; 46(5):1548-1564. PubMed ID: 37529731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease.
    Joshi RS; Jagdale SS; Bansode SB; Shankar SS; Tellis MB; Pandya VK; Chugh A; Giri AP; Kulkarni MJ
    J Biomol Struct Dyn; 2021 Jun; 39(9):3099-3114. PubMed ID: 32329408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.